ALX Oncology Holdings Inc.
ALXO
$1.91
-$0.10-4.75%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 30.61% | 31.65% | 24.59% | 28.55% | 32.00% |
| Total Depreciation and Amortization | -25.31% | 34.41% | 40.94% | 49.36% | 60.35% |
| Total Amortization of Deferred Charges | 2.58% | 4.85% | 5.66% | 6.54% | 5.45% |
| Total Other Non-Cash Items | -58.85% | -43.58% | -35.17% | -22.80% | -3.67% |
| Change in Net Operating Assets | 97.93% | -22.28% | 102.70% | -174.42% | -204.11% |
| Cash from Operations | 32.91% | 28.09% | 30.98% | 24.96% | 22.05% |
| Capital Expenditure | 45.57% | 43.73% | 52.57% | 58.32% | -134.46% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -160.25% | -156.83% | -4.50% | 183.58% | 382.72% |
| Cash from Investing | -160.54% | -157.30% | -4.25% | 187.13% | 362.57% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -306.13% | -178.31% | -64.93% | 4.18% | -72.49% |
| Issuance of Common Stock | 25,287.71% | 8,531.79% | -98.08% | -99.91% | -99.09% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2,157.07% | -130.18% | -94.31% | -97.06% | -96.75% |
| Cash from Financing | 33,134.83% | 403.28% | -98.83% | -99.99% | -99.53% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.86% | 77.54% | 75.33% | 310.80% | 116.74% |